Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf (CIO ABCD)
Research facility
Location:
Aachen, Bonn, Köln, Düsseldorf,
Germany (DE)
ISNI: -
ROR: https://ror.org/04f2wf871
Telomere length screening in young patients with head and neck squamous cell carcinoma is suitable to detect underlying inherited telomere biology disorders (2021)
Tometten M, Rolles B, Klein M, Ooms M, Winnand P, Simons E, Bourgeois M, et al.
Conference contribution
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021)
Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al.
Journal article
Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients (2021)
Persa OD, Schatton K, Rübben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T
Journal article
Symptoms During Outpatient Cancer Treatment and Options for their Management (2021)
Tewes M, Baumann F, Teufel M, Ostgathe C
Journal article, Review article
Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination (2017)
Heindl LM, Koch KR, Hermann MM, Merkelbach-Bruse S, Schultheis AM, Wagener S, Buettner R, et al.
Journal article
Psychooncological counseling and treatment as part of the Comprehensive Cancer Center (CCC): Multicenter study to detect the psycho-oncological needs, indications and using (2016)
Buettner-Teleaga A, Weis J, Goerling U, Hornemann B, Erim Y, Beckmann M, Senf B, et al.
Conference contribution
Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutions (2014)
Eigentler TK, Schlaak M, Hassel JC, Loquai C, Stoffels I, Gutzmer R, Paetzold S, et al.
Journal article